申请人:Baumann Karl
公开号:US20080242710A1
公开(公告)日:2008-10-02
3a,4,5,6-Tetrahydro-pyrrolol,2-b]-isothiazoles wherein the sulphur is in the form of a dioxide and their use for the treatment or prevention of disorders mediated by interactions of LFA-1 with its ligands involved in cell adhesion, migration and activation.
3a,4,5,6-四氢吡咯[2-b]-异噻唑,其中硫以二氧化硫的形式存在,以及它们用于治疗或预防由LFA-1与其参与细胞粘附、迁移和激活的配体相互作用介导的疾病。